The Report Guru

 According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 A pacemaker is a medical device used when the heart is unable to produce electrical impulses naturally. When the heart’s natural pacemaker is defective or when the electrical pathways of the heart are blocked, it can cause irregular heartbeats, as known as arrhythmias. A pacemaker uses electrical pulses to prompt the heart to beat at a normal rate to treat arrhythmias. Recent Developments: • In November 2017, Medtronic received FDA approval and launched the Azure pacemaker with BlueSync technology in the US market • In February 2017, Medtronic received CE Mark certification for its Next Generation Cardiac Resynchronization Therapy-Pacemakers • In February 2017, Abbott Laboratories received FDA approval for the Assu...

 According to the new market research report ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the diagnostic electrocardiograph market. Asia Pacific diagnostic ECG market is expected to grow at the highest CAGR during the forecast period On the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less string...

  According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900 Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market. North America to dominate the competent cells market in 2017 By region, the global competent cells market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America is expected to account for the largest share of the market. This can be attributed to the increasing intensity of research due to technological advancement and increasing commercial needs for genomic and protein expressed products, in North American countries. By applic...

  According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Newer and advanced technologies necessitate the incorporation of advanced manufacturing methods, which result in increased overall costs. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851 Factors such as increasing automation in the manufacturing of medical devices and advanced technologies integrating electronics and medical devices are expected to drive the growth of the medical device contract manufacturing market. Medical device contract manufacturers specialize in a certain process or task and offer expertise from the frequent practice of their manufacturing. Service or services for customers, clients, and inventors of medical devices include product concept and development, process validation and verification, production, or highly spe...

  Factors such as the growing industrial applications of hyperspectral imaging and increasing funding and investments are driving the growth of the global hyperspectral imaging systems market . According to the new market research report Hyperspectral Imaging Systems Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 The prominent players in this hyperspectral imaging systems market include Headwall Photonics, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Corning Incorporated (US), Norsk Elektro Optikk AS (Norway), Raytheon Company (US), Resonon Inc. (US), Telops (Canada), Surface Optics Corporation (US), Applied Spectral Imaging Ltd. (US), ChemImage Corporation (US), Cubert GmbH (Germany), BaySpec, Inc. (US). Players in this market focused on product launches, partnerships, agreements, collaborations, and acquisitions to...

 According to research report the medical image management system market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338 Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management system market. On the other hand, budgetary constraints and longer product lifecycle of VNA may limit market growth to a certain extent during the forecast period. North America to dominate the market in 2018 In 2018, North America is expected to command the largest s...

  According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market. Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast period The APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period. Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical d...